5-fluorouracil, leucovorin, and irinotecan (FOLFIRI) as a third-line chemotherapy treatment in metastatic gastric cancer, after failure of fluoropyrimidine, platinum, anthracycline, and taxane. Biomol Biomed [Internet]. 2018 May 20 [cited 2024 Apr. 27];18(2):170-7. Available from: https://bjbms.org/ojs/index.php/bjbms/article/view/2258